Skip to content

The value of inspiratory muscle training on post-stroke sarcopenia and its effect on rehabilitation outcomes: A randomized controlled trial

The value of inspiratory muscle training on post-stroke sarcopenia and its effect on rehabilitation outcomes: A randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200057067
Enrollment
Unknown
Registered
2022-02-27
Start date
2021-12-01
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

Experimental group:Respiratory training+Conventional treatment
Control group:Conventional treatment

Sponsors

Deyang City People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. First unilateral stroke meeting the diagnostic criteria for stroke established at the Fourth National Academic Conference on Cerebrovascular Diseases in 1995; 2. A course of disease 18.5 kg/m2; 5. Stable vital signs with no tracheal intubation and tracheotomy; 6. An ability to actively cooperate with the training without obvious cognitive impairment (MMSE score >=24 points).

Exclusion criteria

Exclusion criteria: 1. Aged =4, with calf circumferences below the threshold for men < 34 cm and women < 33cm); 3. An inability to complete the inspiratory muscle training due to severe facial paralysis or other oropharyngeal structural abnormalities.

Design outcomes

Primary

MeasureTime frame
Incidence of sarcopenia after stroke;

Secondary

MeasureTime frame
Activities of daily living scale (ADL);Modified rankin scale, mRs;Mini-mental State Examination, MMSE;Trunk Injury Scale (TIS);Meters walked during the Six-Minute Walk Test;Fatigue Severity scale;Occurrent rate of pulmonary infection;

Countries

China

Contacts

Public ContactZhao Qianping

Deyang City People's Hospital

qianpingzhaocqmu@126.com+86 138 9029 7478

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026